Inorevia develops a new generation of instruments to automate and miniaturize molecular biology and sample preparation protocols, through the combination of micro-fluidics and magnetic particles. Its technologies allow complex biochemical analyses to be performed in low volumes and have shown improved reproducibility, cost reduction and analytical versatility, while remaining fully compatible with existing protocols.
Year of creation: 2016
Line of business: Scientific Instrumentation
Institut Curie: Technology-based
By using a unique and patented combination of microfluidics and magnetic particles, Inorevia's technology enables the automation of high througput, low volumes biological analyses. A magnetic clamp capable of moving metal microbeads coated with a biological material (antibodies, protein, DNA, RNA...) into a circulating fluid.
The technologies developped by Inorevia manipulates nanoliter volumes, drastically reducing reagents and samples consumptions. Parallelization and complete automation accelerate complex biology protocols and reduce downtimes. Computer-assisted flow control and contamination-free technology ensure robustness and reproducibility of results.
Inorevia's protocol-agnostic technology is compatible with a wide range of applications in biology and medicine. These technological breakthroughs have direct applications in the fields of research, pharmaceuticals, but also in the biotechnology and medical diagnostics industry.
The company aims at accelerating innovation in Life Science through the development of robust and highly innovative lab instruments.
More about Inorevia: